Commodore Capital LP Makes New Investment in Adverum Biotechnologies, Inc. (NASDAQ:ADVM)
Commodore Capital LP acquired a new position in shares of Adverum Biotechnologies, Inc. (NASDAQ:ADVM – Free Report) during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm acquired 5,000,000 shares of the biotechnology company’s stock, valued at approximately $3,587,000. Adverum Biotechnologies accounts for 0.5% […]